The State of the US Biomedical and Health Research Enterprise: Report Release Event

The U.S. biomedical research enterprise contributes significantly to the nation’s health and economy. An author group conducted a thorough review to determine whether the enterprise can continue to lead globally and address our population’s health needs in the face of complex challenges. This report presents the results of that review and lays out priorities to reimagine and reinvigorate the biomedical research enterprise before a moment of crisis. In this webinar hosted by NAM President Victor J. Dzau, a panel of author group members presented an overview of the report followed by a discussion with national leaders in biomedical research.